By SCM REPORTER
RUSSIAN scientists claim to have developed a “breakthrough” new drug to tackle Parkinson’s disease.
In a move that could offer hope to millions, the Kremlin has announced that the experimental treatment is ready to move into the next phase of testing. Government officials in Moscow confirmed that preclinical trials are set to begin “soon” to determine if the drug is safe and effective.
Parkinson’s is a devastating condition that causes the brain to become progressively damaged over many years, leading to tremors, slow movement, and muscle stiffness.
Details on how the drug actually works are currently being kept under wraps by Russian authorities.
However, the Russian Government’s official reports suggest the treatment could represent a major leap forward in managing the symptoms of the incurable disease.
While the news has sparked excitement, medical experts in the West are likely to remain cautious until the full data from the trials is published and peer-reviewed.
If the preclinical trials—which usually involve testing on cells and animals—are successful, the drug will then face rigorous human clinical trials.
A spokesperson for the Russian Government stated: “The development of this drug is a priority. We are looking to move to the preclinical stage immediately to ensure this breakthrough reaches those who need it.”
